Source file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.930
NY RF TN Sek / PT TAISHO PHARMACEUTICAL INDONESIA TBK. Head Office: Millennium Centennial Center 8th fl, JL Jend. Sudirman Kav. 25 Jakarta 12920, INDONESIA - Phone: #62 21 3970 6720 Technical Operations: Jl. Raya Jakarta-Bogor Km. 38, Cilangkap, Tapos PT TAISHO PHARMACEUTICAL INDONESIA Tbk SURAT PERNYATAAN DEWAN DIREKSI TENTANG TANGGUNG JAWAB ATAS LAPORAN KEUANGAN UNTUK PERIODE YANG BERAKHIR PADA 30 JUNI 2025 Depok 16458, INDONESIA - Phone: #62 21 875 2583 / 875 2584 Website: www.taisho.co.id Kami, yang bertanda tangan di bawah ini: 1. Nama Alamat kantor Alamat domisili atau sesuai KTP Nomor telepon Jabatan Nama Alamat kantor Alamat domisili atau sesuai KTP Nomor telepon Jabatan Taikan Abe Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 #021-3970 6720 Direktur /Director Edwin Isfandiari Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 Millennium Centennial Center 8th floor, Jl. Jend. Sudirman Kav. 25, Jakarta 12920 #021-3970 6720 Direktur /Director PT TAISHO PHARMACEUTICAL INDONESIA Tbk BOARD OF DIRECTORS' STATEMENT REGARDING THE RESPONSIBILITY FOR THE FINANCIAL STATEMENTS FOR THE PERIOD THEN ENDED OF JUNE 30, 2025 We, the undersigned below: Name Office address Domicile address or address according to ID Telephone number Tille Name Office address Domicile address or address according to ID Telephone number Title menyatakan bahwa: 1. Kami bertanggung jawab atas penyusunan dan penyajian laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk, 2. Laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk telah disusun dan disajikan sesuai dengan Standar Akuntansi Keuangan di Indonesia, 3. a. Semua informasi dalam laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk telah dimuat secara lengkap dan benar, dan b. Laporan keuangan PT Taisho Pharmaceutical Indonesia Tbk tidak mengandung informasi atau fakta material yang tidak benar, dan tidak menghilangkan informasi atau fakta material, . The financial declare that: . We are responsible for the preparation and presentation of the financial statemenis of PT Taisho Pharmaceutical Indonesia Tbk, statements of PT Taisho Pharmaceutical Indonesia Tbk have been prepared and presented in accordance with Indonesian Financial Accounting Standards: ..a. All information in the financial statements of PT Taisho Pharmaceutical Indonesia Tbk have been fully disclosed in a complete and truthful manner, and b. The financial statements of PT Taisho Pharmaceutical Indonesia Tbk do not contain any incorrect information or material fact, nor do they omit any information or material fact:
Page 2 OCR 0.907
PT TAISHO PHARMAACEUTICAL INDONESIA TBK. Head Office: Millennium Centennial Center 8th fl, JL. Jend. Sudirman Kav. 25 Jakarta 12920, INDONESIA - Phone: #62 21 3970 6720 Technical Operations: Jl. Raya Jakarta-Bogor Km. 38, Cilangkap, Tapos Depok 16458, INDONESIA - Phone: #62 21 875 2583 / 875 2584 Website: www.taisho.co.id 4. Kami bertanggungjawab atas sistem pengendalian 4. We are responsible for the internal control system internal '— dalam PT Taisho Pharmaceutical of PT Taisho Pharmaceutical Indonesia Tbk. Indonesia Tbk. Demikian pernyataan ini dibuat dengan sebenarnya. This statement is made truthfully. Jakarta, 31 Juli 2025/ Jakarta, July 31, 2025 1 Taikan Abe Edwin Isfandiari Direksi/Director Direksi/Director EAMX382039365
Names mentioned 3 people and organisations named in the text · linked when the evidence is strong
unresolved
org
TAISHO PHARMACEUTICAL INDONESIA TBK.
p.1 ×24
unresolved
org
TAISHO PHARMAACEUTICAL INDONESIA TBK.
p.2 ×2
unresolved
org
PT Taisho Pharmaceutical
p.2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.